1. Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, to Board of Directors

    Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, to Board of Directors

    He was previously Director of the Division of Pulmonary, Allergy, and ... We are thrilled to welcome him to the PTI board of directors ," said Meenu ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. With its next generation CFTR modulators, Proteostasis has demonstrated the promise of becoming a highly-credible new entrant into the CF marketplace.
  3. Topics Mentioned